Aurinia Pharmaceuticals (AUPH) Ownership - Who Owns Aurinia Pharmaceuticals?

2,156 Followers

Aurinia Pharmaceuticals (AUPH) Ownership Overview

13.26% Insiders

4.70% Mutual Funds

18.96% Other Institutional Investors

7.25% ETFs

55.83% Public Companies and

Individual Investors

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 30.91% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 55.83% is owned by Public Companies and Individual Investors.

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 23.66% of the company’s stock is owned by Institutional Investors, 13.26% is owned by Insiders, and 7.25% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jun 02, 2026	Kevin Tang	xxxxxxxxxxxxx	$12455227
Aug 05, 2025	Greg Keenan	xxxxxxxxxxxxx	$210000
Aug 05, 2025	Kevin Tang	xxxxxxxxxxxxx	$13590000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
13,044,106	Insider	10.14%	224,749,946
5,234,647	Institution	4.07%	90,192,968
1,864,706	Institution	1.45%	32,128,884
1,744,866	Insider	1.36%	30,064,041
1,269,557	Institution	0.99%	21,874,467
1,253,869	Institution	0.98%	21,604,163
746,204	Institution	0.58%	12,857,095
710,464	Institution	0.55%	12,241,295
662,900	Insider	0.52%	11,421,767
621,402	Insider	0.48%	10,706,756

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,864,706	Institution	1.45%	32,128,884
1,269,557	Institution	0.99%	21,874,467
710,464	Institution	0.55%	12,241,295
431,177	Institution	0.34%	7,429,180
336,741	Institution	0.26%	5,802,047
172,372	Institution	0.13%	2,969,970
111,924	Institution	0.09%	1,928,451
92,212	Institution	0.07%	1,588,813
84,000	Institution	0.07%	1,447,320
80,526	Institution	0.06%	1,387,463

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	2,810,418	Institution	2.19%	52,329,983
iShares Russell 2000 Growth ETF	985,594	Institution	0.77%	18,351,760
iShares Biotechnology ETF	785,849	Institution	0.61%	14,632,508
Vanguard Russell 2000 ETF	613,258	Institution	0.48%	9,401,245
Janus Henderson Small/Mid Cap Growth Alpha ETF	551,625	Institution	0.43%	9,863,055
Fidelity Enhanced Small Cap ETF	320,580	Institution	0.25%	5,731,970
Vanguard Health Care ETF	318,875	Institution	0.25%	4,888,354
Avantis U.S Small Cap Equity ETF	240,521	Institution	0.19%	4,478,501
Janus Henderson Small Cap Growth Alpha ETF	194,579	Institution	0.15%	3,479,073
Principal U.S. Small-Cap Multi-Factor ETF	122,766	Institution	0.10%	2,195,056

FAQ

Who Owns Aurinia Pharmaceuticals (AUPH)?

According to the latest TipRanks data, approximately 18.96% of the company's stock is held by institutional investors, 13.26% is held by insiders, and 55.83% is held by retail investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?

According to the latest TipRanks data, approximately 18.96% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?

According to the latest TipRanks data, approximately 55.83% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.

Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?

Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.